Apogee Therapeutics, Inc.(NasdaqGM:APGE) added to S&P Biotechnology Select Industry Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.42 USD | -1.08% | +4.08% | +90.94% |
May. 13 | Apogee Therapeutics' Q1 Net Loss Widens | MT |
May. 13 | Apogee Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.94% | 3.16B | |
+29.45% | 49.18B | |
+1.05% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.64% | 26.09B | |
-22.68% | 18.71B | |
+8.00% | 13.26B | |
+32.23% | 12.32B | |
-0.90% | 11.99B |
- Stock Market
- Equities
- APGE Stock
- News Apogee Therapeutics, Inc.
- Apogee Therapeutics, Inc.(NasdaqGM: APGE) added to S&P Biotechnology Select Industry Index